| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | 10% Owner | Director
3 companies
Springer Timothy A is a Director, 10% Owner at Cartesian Therapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 49 buys and 0 sells.
Estimated insider holdings value: $221.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 11, 2025 | RNAC Cartesian Therapeutics, Inc. | Director, 10% Owner | Buy | 149,075 | $10.21 | $1,522,517.04 | +0.3% | +26.9% | -44.0% | |
| Apr 11, 2025 | TECX Tectonic Therapeutic, Inc. | Director, 10% Owner | Buy | 141,923 | $16.20 | $2,299,014.65 | +0.6% | +34.4% | +90.1% | |
| Apr 7, 2025 | TECX Tectonic Therapeutic, Inc. | Director, 10% Owner | Buy | 500,000 | $17.10 | $8,550,000.00 | +9.6% | +33.8% | +87.0% | |
| Mar 20, 2025 | RNAC Cartesian Therapeutics, Inc. | Director, 10% Owner | Buy | 89,863 | $15.26 | $1,371,154.37 | +0.4% | -37.2% | -59.1% | |
| Feb 5, 2025 | TECX Tectonic Therapeutic, Inc. | Director, 10% Owner | Buy | 789,294 | $50.68 | $39,999,977.16 | +17.9% | -59.6% | -51.2% | |
| Jan 14, 2025 | RNAC Cartesian Therapeutics, Inc. | Director, 10% Owner | Buy | 20,967 | $17.47 | $366,353.71 | - | -27.9% | -57.6% | |
| Dec 23, 2024 | RNAC Cartesian Therapeutics, Inc. | Director, 10% Owner | Buy | 52,189 | $18.49 | $965,020.79 | +0.1% | -17.6% | -66.8% | |
| Nov 18, 2024 | RNAC Cartesian Therapeutics, Inc. | Director, 10% Owner | Buy | 431,940 | $17.07 | $7,373,527.21 | +1.1% | +5.1% | -59.0% | |
| Oct 22, 2024 | TECX Tectonic Therapeutic, Inc. | Director, 10% Owner | Buy | 300,000 | $33.59 | $10,077,000.00 | +7.9% | +14.0% | -51.3% | |
| Oct 4, 2024 | RNAC Cartesian Therapeutics, Inc. | Director, 10% Owner | Buy | 205,721 | $20.87 | $4,293,544.83 | +0.3% | -31.0% | -58.4% |